References
Buckingham RE, Hamilton TC, Robson D. Effect of intracerebroventricular 5,6-dihydroxytryptamine on blood pressure of spontaneously hypertensive rats. European Journal of Pharmacology 36: 431–437, 1976
De Clerck F, Jageneau A, Dom J. Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogs. Archives Internationales de Pharmacodynamic et de Thérapie 258: 100–115, 1982
Fujita T, Sato Y, Ando K, Noda H, Ueno N, et al. Dynamic responses of active and inactive renin and plasma norepinephrine during exercise in normal man. Japanese Heart Journal 23: 545–551, 1982a
Fujita T, Ando K, Noda H, Sato Y, Yamashita N, et al. Hemodynamic and endocrine changes associated with Captopril in diuretic-resistant hypertensive patients. American Journal of Medicine 73: 341–347, 1982b
Hedner T, Pettersson A, Persson B. Blood pressure reduction and pharmacokinetics of ketanserin in patients with essential hypertension. Satellite symposium to the 2nd European Meeting on Hypertension, Milan, June 9, 1985. Abstract, p. 35, 1985
Janssen PAJ. 5-HT2 receptor blockade to study serotonin-induced pathology. Trends in Pharmacological Sciences 4: 198–206, 1983
Jarrott B, McQueen A, Graf L, Louis WJ. Serotonin levels in vascular tissue and the effects of a serotonin synthesis inhibitor on blood pressure in hypertensive rats. Clinical and Experimental Pharmacology and Physiology (Suppl. 2): 201–205, 1975
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, et al. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sciences 28: 1015–1022, 1981
Noda H, Fujita T. Left ventricular hypertrophy in young patients with borderline hypertension. Nippon Naika Gakkai Zasshi (Journal of the Japanese Society of Internal Medicine) 76: 1211–1217, 1987
Pettersson A, Gradin K, Hedner T, Persson ?. Antihypertensive mechanism of action of ketanserin and some ketanserin dialogues in the spontaneously hypertensive rat. Naunyn-Schmiedeberg’s Archives of Pharmacology 329: 394–397, 1985
Schalekamp MADH. Haemodynamic effects of ketanserin: mechanism of the antihypertensive action. Satellite symposium to the 2nd European Meeting on Hypertension, Milan, June 9, 1985. Abstract, p. 9, 1985
Wenting GJ, Woittiez AJJ, Man in’t Veld AJ, Schalekamp MADH. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Noda, H., Isaka, M., Ito, Y. et al. Haemodynamic Changes Associated with Long Term Antihypertensive Therapy with Ketanserin. Drugs 36 (Suppl 1), 115–119 (1988). https://doi.org/10.2165/00003495-198800361-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800361-00022